These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1223916)

  • 1. Experimental analysis of conditioning factors in human narcotic addiction.
    O'Brien CP
    Pharmacol Rev; 1975 Dec; 27(4):533-43. PubMed ID: 1223916
    [No Abstract]   [Full Text] [Related]  

  • 2. Conditioning of narcotic abstinence symptoms in human subjects.
    O'Brien CP; O'Brien TJ; Mintz J; Brady JP
    Drug Alcohol Depend; 1975 Dec; 1(2):115-23. PubMed ID: 1235105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcotic poisoning: an epidemic disease.
    Kersh ES; Schwartz LK
    Am Fam Physician; 1973 Dec; 8(6):90-7. PubMed ID: 4760436
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-choice discrimination in methadone maintenance patients: hydromorphone, naloxone, and saline.
    Preston KL; Bigelow GE; Stitzer ML; Liebson IA
    NIDA Res Monogr; 1984; 55():151-7. PubMed ID: 6085768
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states.
    Ho AK; Chen RC
    Ann N Y Acad Sci; 1976; 281():297-310. PubMed ID: 1071365
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 9. Reliability of sequential naloxone challenge tests.
    Rosen MI; McMahon TJ; Margolin A; Gill TS; Woods SW; Pearsall HR; Kreek MJ; Kosten TR
    Am J Drug Alcohol Abuse; 1995 Nov; 21(4):453-67. PubMed ID: 8561097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A
    Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary experiences with the treatment of opiate addiction by methadone withdrawal.
    Gudeman JE; Shader RI; Ryan J; Rolde EJ
    Conn Med; 1972 Mar; 36(3):137-42. PubMed ID: 5012267
    [No Abstract]   [Full Text] [Related]  

  • 12. Nature and incidence of conditioned responses in a methadone population: a comparison of laboratory, clinic, and naturalistic settings.
    Childress AR; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1986; 67():366-72. PubMed ID: 3092092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Narcotic withdrawal syndrome. Therapeutic methods].
    Cerdeño Impuesto V
    Rev Clin Esp; 1982 Oct; 167(1):65-9. PubMed ID: 6129686
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various factors which affect the rate of development of tolerance and physical dependence to abused drugs.
    Dewey WL
    NIDA Res Monogr; 1984; 54():39-49. PubMed ID: 6442762
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological treatments for substance use disorders.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Aug; 42(8):14-20. PubMed ID: 15354595
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methadone treatment in opiate addiction].
    Hess JP
    Harefuah; 1972 Aug; 83(4):160-1. PubMed ID: 5083977
    [No Abstract]   [Full Text] [Related]  

  • 18. Addiction and the community. (Narcotic substitution therapy).
    Taylor WJ; Chambers CD; Bowling CE
    Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
    [No Abstract]   [Full Text] [Related]  

  • 19. Conditioned narcotic withdrawal in humans.
    O'Brien CP; Testa T; O'Brien TJ; Brady JP; Wells B
    Science; 1977 Mar; 195(4282):1000-2. PubMed ID: 841320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-precipitated withdrawal in humans after acute morphine administration.
    Bickel WK; Stitzer ML; Wazlavek BE; Liebson IA
    NIDA Res Monogr; 1986; 67():349-54. PubMed ID: 3092089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.